BCKDK Activators
BCKDK activators pertain to a class of chemical agents that specifically target and modulate the activity of the enzyme branched-chain ketoacid dehydrogenase kinase. This enzyme plays a crucial role in the metabolic pathways of branched-chain amino acids (BCAAs) - leucine, isoleucine, and valine - which are essential amino acids necessary for various metabolic processes. BCKDK is a regulatory kinase that phosphorylates the E1 subunit of the branched-chain alpha-ketoacid dehydrogenase (BCKD) complex. The phosphorylation by BCKDK inactivates the BCKD complex, leading to a decrease in the catabolism of BCAAs. Therefore, activators of BCKDK influence this regulatory mechanism, potentially altering the rate of BCAA metabolism.
The alteration of BCAA metabolism by BCKDK activators has significant biochemical implications because of the role of these amino acids in protein synthesis and energy production. BCAAs are unique among amino acids due to their metabolic breakdown pathways which occur primarily in the muscle and not the liver. The precise regulation of BCAA catabolism is essential for maintaining amino acid balance within the body. An increase in BCKDK activity may lead to enhanced phosphorylation, thus slowing the BCAA catabolic process by deactivating the BCKD complex.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol may upregulate BCKDK by activating sirtuin pathways that enhance mitochondrial biogenesis, potentially requiring increased BCKDK activity to manage elevated branched-chain amino acid catabolism. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid could stimulate BCKDK expression through direct binding of retinoic acid receptors to response elements in the BCKDK gene promoter, initiating transcription. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Epigallocatechin Gallate might upregulate BCKDK by inhibiting DNA methyltransferases, resulting in hypomethylation of the BCKDK gene promoter and enhanced transcription. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin may stimulate BCKDK expression by activating transcriptional activators such as NF-κB, which might bind to specific regulatory regions upstream of the BCKDK gene. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium Butyrate could upregulate BCKDK by inhibiting histone deacetylase activity, leading to a more open chromatin structure around the BCKDK gene and facilitating transcription. | ||||||
β-Hydroxyisovaleric acid | 625-08-1 | sc-235338 | 5 g | $500.00 | ||
β-Hydroxyisovaleric acid could increase BCKDK expression through a compensatory response that upregulates mitochondrial enzymes, including BCKDK, in response to an increased demand for branched-chain amino acid catabolism. | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $55.00 $125.00 | 13 | |
Pioglitazone could stimulate BCKDK transcription by binding to PPARγ, which in turn associates with PPAR response elements in the BCKDK promoter region, leading to increased gene expression. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium may upregulate BCKDK expression by inhibiting GSK-3β, which could relieve inhibition on transcription factors that promote BCKDK expression, such as Wnt/β-catenin signaling components. | ||||||
Cholecalciferol | 67-97-0 | sc-205630 sc-205630A sc-205630B | 1 g 5 g 10 g | $71.00 $163.00 $296.00 | 2 | |
Cholecalciferol could enhance BCKDK expression by binding to the vitamin D receptor, which may associate with vitamin D response elements in the BCKDK gene promoter to stimulate transcription. | ||||||